SB-649868 25mg
SB-649868 is an orexin receptor antagonist in development by GlaxoSmithKline.
| Trivial name | SB-649868 25mg |
| Catalog Number | A12651-25 |
| Alternative Name(s) | N-[((2S)-1-{[5-(4-fluorophenyl)-2-methyl-1,3-thiazol-4-yl]carbonyl}-2-piperidinyl)methyl]-1-benzofuran-4-carboxamide; SB-649868; (S)-2-((4-benzofuranyl)carbonylaminomethyl)-1-((4-(2-methyl-5-(4-fluorophenyl))thiazolyl)carbonyl)piperidine |
| Molecular Formula | C26H24FN3O3S |
| CAS# | 380899-24-1 |
| SMILES | CC1=NC(=C(S1)C2=CC=C(C=C2)F)C(=O)N3CCCC[C@H]3CNC(=O)C4=C5C=COC5=CC=C4 |
| Size | 25mg |
| Supplier Page | http://www.adooq.com/sb-649868.html |